Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01350505 · ClinicalTrials.gov registry record · NA
Toileting at Night in Older Adults: Light to Maximize Balance, Minimize Insomnia
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01350505: Completed NA study, sponsored by VA Office of Research and Development.
NCT01350505 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01350505, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
To examine the change in balance that occurs in older individuals when exposed to different colored lights at night.
Primary Outcome
Balance was assessed during a 13-minute nocturnal light exposure (4 different conditions) and differences between the conditions were assessed. To determine goodness of balance while walking, the variability in stride length (i.e., variance in stride-to-stride length) was calculated in each of the conditions. Increased variability in stride length is associated with increased risk of falling.
Interventions
- BEHAVIORAL White light exposure
- BEHAVIORAL Dim white light exposure
- BEHAVIORAL Very dim white light exposure
- BEHAVIORAL Dim orange light exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-10-15 |
| Est. Completion | 2017-06-30 |
| Phase | NA |
What the finished NCT01350505 record still lists
NCT01350505 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which White light exposure is the first listed.
NCT01350505 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01350505 about?
NCT01350505 is a clinical study titled "Toileting at Night in Older Adults: Light to Maximize Balance, Minimize Insomnia". To examine the change in balance that occurs in older individuals when exposed to different colored lights at night.
What is the current status of trial NCT01350505?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2013-10-15. Estimated completion is 2017-06-30.
What interventions are being tested in trial NCT01350505?
The interventions under investigation include: White light exposure (BEHAVIORAL), Dim white light exposure (BEHAVIORAL), Very dim white light exposure (BEHAVIORAL), Dim orange light exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT01350505?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01350505's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI